drugset / Trial / NCT07076459

A Comparative Pharmacokinetic Study of Single-Dose Administration of HR091506 Tablets From Different Batches in Healthy Subjects

NCT07076459

Phase 1 Completed 36 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

To evaluate the pharmacokinetic characteristics of HR091506 tablets in different batches in healthy subjects after single administration.

Timeline

Start
2025-07-10
Primary completion
2025-08-18
Completion
2025-08-18

Drugs

EvaluationDrugModalityDoseRoute
Subject HR091506 Unknown Oral

Indications

No indication recorded.